Suven Life Sciences Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Suven Life Sciences Limited generated cash of -$1,154,690,000, which is less than the previous year. Cash used in financing activities reached the amount of -$10,540,000 last year. Net change in cash is therefore -$220,867,000.
Cash Flow
| 2010 | 129.24M | -100.45M | -18.80M |
|---|---|---|---|
| 2011 | 55.16M | -126.81M | 78.80M |
| 2012 | 335.06M | -317.46M | -18.31M |
| 2016 | 698.77M | -389.04M | -698.48M |
| 2018 | 699.36M | -6.09M | -576.98M |
| 2020 | -1.93B | 2.05B | 27.41M |
| 2021 | -960.23M | 558.40M | 348.55M |
| 2023 | -1.03B | -2.60B | 3.95B |
| 2024 | -1.15B | 944.36M | -10.54M |
SUVEN.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 370.19M | 52.73M | 146.75M | 2.27M | 86.88M | 2.79B | 18.38M | 22.30M | 12.32M |
Operating activities | |||||||||
Net income | -1.05B | -1.18B | -774.74M | -1.06B | 1.95B | 922.36M | 143.62M | 103.99M | 70.00M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 58.16M | 58.26M | 35.24M | 39.63M | 247.63M | 239.52M | 85.45M | 79.05M | 76.97M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -4.78M | 4.90M | 5.08M | 3.73M | -157.04M | -134.78M | 0 | 0 | 0 |
Inventories | -7.08M | 224K | -1.41M | 13.03M | -469.54M | -16.58M | -116.70M | -28.75M | -32.85M |
Accounts payable | 4.03M | -3.21M | -27.86M | -13.03M | 188.76M | -82.86M | 0 | 0 | 0 |
Cash generated by operating activities | -1.15B | -1.03B | -960.23M | -1.93B | 699.36M | 698.77M | 335.06M | 55.16M | 129.24M |
Investing activities | |||||||||
Purchases Of Investments | 0 | -1.04B | 0 | -912.52M | -292K | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -28.94M | -63.04M | -23.85M | -417.92M | -578.62M | -272.74M | -40.35M | -48.26M |
Acquisitions Net | 0 | -64.16M | 0 | -1.31B | 200K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 944.36M | -2.60B | 558.40M | 2.05B | -6.09M | -389.04M | -317.46M | -126.81M | -100.45M |
Financing activities | |||||||||
Common Stock Issued | 0 | 3.97B | 369.2M | 0 | 0 | 0 | 0 | 16.89M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | -190.93M | -398.31M | -33.92M | -33.97M | -33.89M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -4.84M | -6.92M | 32.93M | -244.58M | -218.35M | 0 | 0 | 0 |
Cash used in financing activities | -10.54M | 3.95B | 348.55M | 27.41M | -576.98M | -698.48M | -18.31M | 78.80M | -18.80M |
Net Change In Cash | -220.86M | 317.45M | -53.27M | 144.48M | 116.28M | -388.74M | -714K | 7.15M | 9.98M |
Cash at end of period | 149.32M | 370.19M | 93.48M | 146.75M | 203.16M | 2.40B | 17.67M | 29.46M | 22.30M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |